nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Carmustine—melanoma	0.213	0.328	CbGbCtD
Betaxolol—CYP1A2—Vemurafenib—melanoma	0.168	0.259	CbGbCtD
Betaxolol—CYP2D6—Vemurafenib—melanoma	0.139	0.214	CbGbCtD
Betaxolol—CYP1A2—Dacarbazine—melanoma	0.129	0.199	CbGbCtD
Betaxolol—Flushing—Dactinomycin—melanoma	0.000689	0.00234	CcSEcCtD
Betaxolol—Hypersensitivity—Vemurafenib—melanoma	0.000688	0.00234	CcSEcCtD
Betaxolol—Renal impairment—Docetaxel—melanoma	0.000678	0.0023	CcSEcCtD
Betaxolol—Asthenia—Vemurafenib—melanoma	0.00067	0.00227	CcSEcCtD
Betaxolol—Visual impairment—Carmustine—melanoma	0.000669	0.00227	CcSEcCtD
Betaxolol—Hallucination—Temozolomide—melanoma	0.000668	0.00227	CcSEcCtD
Betaxolol—Hypoaesthesia—Temozolomide—melanoma	0.000668	0.00227	CcSEcCtD
Betaxolol—Pharyngitis—Temozolomide—melanoma	0.000666	0.00226	CcSEcCtD
Betaxolol—Chills—Dactinomycin—melanoma	0.000666	0.00226	CcSEcCtD
Betaxolol—Cardiac failure—Docetaxel—melanoma	0.000661	0.00225	CcSEcCtD
Betaxolol—Pruritus—Vemurafenib—melanoma	0.00066	0.00224	CcSEcCtD
Betaxolol—Lethargy—Docetaxel—melanoma	0.000659	0.00224	CcSEcCtD
Betaxolol—Alopecia—Dactinomycin—melanoma	0.000656	0.00223	CcSEcCtD
Betaxolol—Eye disorder—Carmustine—melanoma	0.000649	0.00221	CcSEcCtD
Betaxolol—Visual impairment—Temozolomide—melanoma	0.000647	0.0022	CcSEcCtD
Betaxolol—Erythema—Dactinomycin—melanoma	0.000646	0.00219	CcSEcCtD
Betaxolol—Flushing—Carmustine—melanoma	0.000645	0.00219	CcSEcCtD
Betaxolol—Ill-defined disorder—Bleomycin—melanoma	0.000643	0.00218	CcSEcCtD
Betaxolol—Anaemia—Bleomycin—melanoma	0.00064	0.00218	CcSEcCtD
Betaxolol—Diarrhoea—Vemurafenib—melanoma	0.000639	0.00217	CcSEcCtD
Betaxolol—Eye disorder—Temozolomide—melanoma	0.000627	0.00213	CcSEcCtD
Betaxolol—Tinnitus—Temozolomide—melanoma	0.000626	0.00213	CcSEcCtD
Betaxolol—Malaise—Bleomycin—melanoma	0.000625	0.00212	CcSEcCtD
Betaxolol—Flushing—Temozolomide—melanoma	0.000623	0.00212	CcSEcCtD
Betaxolol—Cardiac disorder—Temozolomide—melanoma	0.000623	0.00212	CcSEcCtD
Betaxolol—Arrhythmia—Carmustine—melanoma	0.000621	0.00211	CcSEcCtD
Betaxolol—Dizziness—Vemurafenib—melanoma	0.000617	0.0021	CcSEcCtD
Betaxolol—Alopecia—Carmustine—melanoma	0.000614	0.00209	CcSEcCtD
Betaxolol—Angiopathy—Temozolomide—melanoma	0.000609	0.00207	CcSEcCtD
Betaxolol—Mental disorder—Carmustine—melanoma	0.000609	0.00207	CcSEcCtD
Betaxolol—Ataxia—Docetaxel—melanoma	0.000607	0.00206	CcSEcCtD
Betaxolol—Immune system disorder—Temozolomide—melanoma	0.000606	0.00206	CcSEcCtD
Betaxolol—Mediastinal disorder—Temozolomide—melanoma	0.000605	0.00206	CcSEcCtD
Betaxolol—Erythema—Carmustine—melanoma	0.000605	0.00205	CcSEcCtD
Betaxolol—Malnutrition—Carmustine—melanoma	0.000605	0.00205	CcSEcCtD
Betaxolol—Cough—Bleomycin—melanoma	0.000605	0.00205	CcSEcCtD
Betaxolol—Chills—Temozolomide—melanoma	0.000602	0.00205	CcSEcCtD
Betaxolol—Ill-defined disorder—Dactinomycin—melanoma	0.000599	0.00204	CcSEcCtD
Betaxolol—Anaemia—Dactinomycin—melanoma	0.000597	0.00203	CcSEcCtD
Betaxolol—Vomiting—Vemurafenib—melanoma	0.000593	0.00202	CcSEcCtD
Betaxolol—Alopecia—Temozolomide—melanoma	0.000593	0.00202	CcSEcCtD
Betaxolol—Chest pain—Bleomycin—melanoma	0.00059	0.002	CcSEcCtD
Betaxolol—Myalgia—Bleomycin—melanoma	0.00059	0.002	CcSEcCtD
Betaxolol—Rash—Vemurafenib—melanoma	0.000588	0.002	CcSEcCtD
Betaxolol—Mental disorder—Temozolomide—melanoma	0.000588	0.002	CcSEcCtD
Betaxolol—Dermatitis—Vemurafenib—melanoma	0.000588	0.002	CcSEcCtD
Betaxolol—Headache—Vemurafenib—melanoma	0.000585	0.00199	CcSEcCtD
Betaxolol—Malnutrition—Temozolomide—melanoma	0.000584	0.00199	CcSEcCtD
Betaxolol—Erythema—Temozolomide—melanoma	0.000584	0.00199	CcSEcCtD
Betaxolol—Breast disorder—Docetaxel—melanoma	0.000583	0.00198	CcSEcCtD
Betaxolol—Discomfort—Bleomycin—melanoma	0.000583	0.00198	CcSEcCtD
Betaxolol—Malaise—Dactinomycin—melanoma	0.000583	0.00198	CcSEcCtD
Betaxolol—Cramp muscle—Docetaxel—melanoma	0.000581	0.00197	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000581	0.00197	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000581	0.00197	CcSEcCtD
Betaxolol—Nasopharyngitis—Docetaxel—melanoma	0.000577	0.00196	CcSEcCtD
Betaxolol—Dysgeusia—Temozolomide—melanoma	0.000572	0.00194	CcSEcCtD
Betaxolol—Confusional state—Bleomycin—melanoma	0.00057	0.00194	CcSEcCtD
Betaxolol—Vision blurred—Carmustine—melanoma	0.00057	0.00194	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Docetaxel—melanoma	0.000569	0.00193	CcSEcCtD
Betaxolol—Tremor—Carmustine—melanoma	0.000567	0.00192	CcSEcCtD
Betaxolol—Oedema—Bleomycin—melanoma	0.000565	0.00192	CcSEcCtD
Betaxolol—Infection—Bleomycin—melanoma	0.000562	0.00191	CcSEcCtD
Betaxolol—Anaemia—Carmustine—melanoma	0.000559	0.0019	CcSEcCtD
Betaxolol—Dysphagia—Docetaxel—melanoma	0.000558	0.00189	CcSEcCtD
Betaxolol—Nausea—Vemurafenib—melanoma	0.000554	0.00188	CcSEcCtD
Betaxolol—Thrombocytopenia—Bleomycin—melanoma	0.000554	0.00188	CcSEcCtD
Betaxolol—Vision blurred—Temozolomide—melanoma	0.000551	0.00187	CcSEcCtD
Betaxolol—Myalgia—Dactinomycin—melanoma	0.00055	0.00187	CcSEcCtD
Betaxolol—Bronchospasm—Docetaxel—melanoma	0.000549	0.00186	CcSEcCtD
Betaxolol—Tremor—Temozolomide—melanoma	0.000548	0.00186	CcSEcCtD
Betaxolol—Discomfort—Dactinomycin—melanoma	0.000543	0.00185	CcSEcCtD
Betaxolol—Angina pectoris—Docetaxel—melanoma	0.000543	0.00185	CcSEcCtD
Betaxolol—Ill-defined disorder—Temozolomide—melanoma	0.000542	0.00184	CcSEcCtD
Betaxolol—Anaemia—Temozolomide—melanoma	0.00054	0.00183	CcSEcCtD
Betaxolol—Anorexia—Bleomycin—melanoma	0.000539	0.00183	CcSEcCtD
Betaxolol—Hypotension—Bleomycin—melanoma	0.000528	0.00179	CcSEcCtD
Betaxolol—Oedema—Dactinomycin—melanoma	0.000527	0.00179	CcSEcCtD
Betaxolol—Malaise—Temozolomide—melanoma	0.000527	0.00179	CcSEcCtD
Betaxolol—Vertigo—Temozolomide—melanoma	0.000525	0.00178	CcSEcCtD
Betaxolol—Infection—Dactinomycin—melanoma	0.000524	0.00178	CcSEcCtD
Betaxolol—Palpitations—Temozolomide—melanoma	0.000516	0.00175	CcSEcCtD
Betaxolol—Thrombocytopenia—Dactinomycin—melanoma	0.000516	0.00175	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000515	0.00175	CcSEcCtD
Betaxolol—Myalgia—Carmustine—melanoma	0.000515	0.00175	CcSEcCtD
Betaxolol—Chest pain—Carmustine—melanoma	0.000515	0.00175	CcSEcCtD
Betaxolol—Anxiety—Carmustine—melanoma	0.000513	0.00174	CcSEcCtD
Betaxolol—Cough—Temozolomide—melanoma	0.00051	0.00173	CcSEcCtD
Betaxolol—Paraesthesia—Bleomycin—melanoma	0.000508	0.00172	CcSEcCtD
Betaxolol—Weight increased—Docetaxel—melanoma	0.000508	0.00172	CcSEcCtD
Betaxolol—Weight decreased—Docetaxel—melanoma	0.000505	0.00171	CcSEcCtD
Betaxolol—Dyspnoea—Bleomycin—melanoma	0.000504	0.00171	CcSEcCtD
Betaxolol—Anorexia—Dactinomycin—melanoma	0.000503	0.00171	CcSEcCtD
Betaxolol—Pneumonia—Docetaxel—melanoma	0.0005	0.0017	CcSEcCtD
Betaxolol—Confusional state—Carmustine—melanoma	0.000498	0.00169	CcSEcCtD
Betaxolol—Arthralgia—Temozolomide—melanoma	0.000498	0.00169	CcSEcCtD
Betaxolol—Myalgia—Temozolomide—melanoma	0.000498	0.00169	CcSEcCtD
Betaxolol—Infestation—Docetaxel—melanoma	0.000497	0.00169	CcSEcCtD
Betaxolol—Infestation NOS—Docetaxel—melanoma	0.000497	0.00169	CcSEcCtD
Betaxolol—Anxiety—Temozolomide—melanoma	0.000496	0.00168	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000494	0.00168	CcSEcCtD
Betaxolol—Oedema—Carmustine—melanoma	0.000494	0.00168	CcSEcCtD
Betaxolol—Discomfort—Temozolomide—melanoma	0.000492	0.00167	CcSEcCtD
Betaxolol—Decreased appetite—Bleomycin—melanoma	0.000492	0.00167	CcSEcCtD
Betaxolol—Infection—Carmustine—melanoma	0.00049	0.00167	CcSEcCtD
Betaxolol—Acute coronary syndrome—Docetaxel—melanoma	0.00049	0.00167	CcSEcCtD
Betaxolol—Neuropathy peripheral—Docetaxel—melanoma	0.000487	0.00166	CcSEcCtD
Betaxolol—Myocardial infarction—Docetaxel—melanoma	0.000487	0.00166	CcSEcCtD
Betaxolol—Dry mouth—Temozolomide—melanoma	0.000487	0.00165	CcSEcCtD
Betaxolol—Stomatitis—Docetaxel—melanoma	0.000485	0.00165	CcSEcCtD
Betaxolol—Pain—Bleomycin—melanoma	0.000484	0.00164	CcSEcCtD
Betaxolol—Conjunctivitis—Docetaxel—melanoma	0.000483	0.00164	CcSEcCtD
Betaxolol—Thrombocytopenia—Carmustine—melanoma	0.000483	0.00164	CcSEcCtD
Betaxolol—Tachycardia—Carmustine—melanoma	0.000482	0.00164	CcSEcCtD
Betaxolol—Confusional state—Temozolomide—melanoma	0.000481	0.00163	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00048	0.00163	CcSEcCtD
Betaxolol—Oedema—Temozolomide—melanoma	0.000477	0.00162	CcSEcCtD
Betaxolol—Infection—Temozolomide—melanoma	0.000474	0.00161	CcSEcCtD
Betaxolol—Anorexia—Carmustine—melanoma	0.00047	0.0016	CcSEcCtD
Betaxolol—Epistaxis—Docetaxel—melanoma	0.000469	0.00159	CcSEcCtD
Betaxolol—Nervous system disorder—Temozolomide—melanoma	0.000468	0.00159	CcSEcCtD
Betaxolol—Thrombocytopenia—Temozolomide—melanoma	0.000467	0.00159	CcSEcCtD
Betaxolol—Feeling abnormal—Bleomycin—melanoma	0.000466	0.00158	CcSEcCtD
Betaxolol—Agranulocytosis—Docetaxel—melanoma	0.000464	0.00158	CcSEcCtD
Betaxolol—Skin disorder—Temozolomide—melanoma	0.000463	0.00157	CcSEcCtD
Betaxolol—Hypotension—Carmustine—melanoma	0.000461	0.00157	CcSEcCtD
Betaxolol—Hyperhidrosis—Temozolomide—melanoma	0.000461	0.00157	CcSEcCtD
Betaxolol—Decreased appetite—Dactinomycin—melanoma	0.000458	0.00156	CcSEcCtD
Betaxolol—Fatigue—Dactinomycin—melanoma	0.000455	0.00154	CcSEcCtD
Betaxolol—Anorexia—Temozolomide—melanoma	0.000455	0.00154	CcSEcCtD
Betaxolol—Pain—Dactinomycin—melanoma	0.000451	0.00153	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Carmustine—melanoma	0.00045	0.00153	CcSEcCtD
Betaxolol—Urticaria—Bleomycin—melanoma	0.000449	0.00153	CcSEcCtD
Betaxolol—Chlorphenesin—PTGS2—melanoma	0.000448	0.275	CrCbGaD
Betaxolol—Rhinitis—Docetaxel—melanoma	0.000448	0.00152	CcSEcCtD
Betaxolol—Body temperature increased—Bleomycin—melanoma	0.000447	0.00152	CcSEcCtD
Betaxolol—Insomnia—Carmustine—melanoma	0.000446	0.00152	CcSEcCtD
Betaxolol—Hypoaesthesia—Docetaxel—melanoma	0.000444	0.00151	CcSEcCtD
Betaxolol—Paraesthesia—Carmustine—melanoma	0.000443	0.00151	CcSEcCtD
Betaxolol—Pharyngitis—Docetaxel—melanoma	0.000443	0.00151	CcSEcCtD
Betaxolol—Dyspnoea—Carmustine—melanoma	0.00044	0.00149	CcSEcCtD
Betaxolol—Feeling abnormal—Dactinomycin—melanoma	0.000435	0.00148	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000435	0.00148	CcSEcCtD
Betaxolol—Insomnia—Temozolomide—melanoma	0.000431	0.00147	CcSEcCtD
Betaxolol—Visual impairment—Docetaxel—melanoma	0.00043	0.00146	CcSEcCtD
Betaxolol—Decreased appetite—Carmustine—melanoma	0.000429	0.00146	CcSEcCtD
Betaxolol—Paraesthesia—Temozolomide—melanoma	0.000428	0.00145	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Carmustine—melanoma	0.000426	0.00145	CcSEcCtD
Betaxolol—Dyspnoea—Temozolomide—melanoma	0.000425	0.00144	CcSEcCtD
Betaxolol—Constipation—Carmustine—melanoma	0.000422	0.00143	CcSEcCtD
Betaxolol—Pain—Carmustine—melanoma	0.000422	0.00143	CcSEcCtD
Betaxolol—Dyspepsia—Temozolomide—melanoma	0.00042	0.00143	CcSEcCtD
Betaxolol—Eye disorder—Docetaxel—melanoma	0.000417	0.00142	CcSEcCtD
Betaxolol—Body temperature increased—Dactinomycin—melanoma	0.000417	0.00142	CcSEcCtD
Betaxolol—Hypersensitivity—Bleomycin—melanoma	0.000417	0.00142	CcSEcCtD
Betaxolol—Decreased appetite—Temozolomide—melanoma	0.000415	0.00141	CcSEcCtD
Betaxolol—Cardiac disorder—Docetaxel—melanoma	0.000414	0.00141	CcSEcCtD
Betaxolol—Flushing—Docetaxel—melanoma	0.000414	0.00141	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Temozolomide—melanoma	0.000412	0.0014	CcSEcCtD
Betaxolol—Fatigue—Temozolomide—melanoma	0.000411	0.0014	CcSEcCtD
Betaxolol—Pain—Temozolomide—melanoma	0.000408	0.00139	CcSEcCtD
Betaxolol—Constipation—Temozolomide—melanoma	0.000408	0.00139	CcSEcCtD
Betaxolol—Feeling abnormal—Carmustine—melanoma	0.000407	0.00138	CcSEcCtD
Betaxolol—Asthenia—Bleomycin—melanoma	0.000406	0.00138	CcSEcCtD
Betaxolol—Angiopathy—Docetaxel—melanoma	0.000405	0.00138	CcSEcCtD
Betaxolol—Immune system disorder—Docetaxel—melanoma	0.000403	0.00137	CcSEcCtD
Betaxolol—Mediastinal disorder—Docetaxel—melanoma	0.000402	0.00137	CcSEcCtD
Betaxolol—Chills—Docetaxel—melanoma	0.000401	0.00136	CcSEcCtD
Betaxolol—Pruritus—Bleomycin—melanoma	0.0004	0.00136	CcSEcCtD
Betaxolol—Arrhythmia—Docetaxel—melanoma	0.000399	0.00135	CcSEcCtD
Betaxolol—Alopecia—Docetaxel—melanoma	0.000395	0.00134	CcSEcCtD
Betaxolol—Feeling abnormal—Temozolomide—melanoma	0.000393	0.00134	CcSEcCtD
Betaxolol—Mental disorder—Docetaxel—melanoma	0.000391	0.00133	CcSEcCtD
Betaxolol—Body temperature increased—Carmustine—melanoma	0.00039	0.00133	CcSEcCtD
Betaxolol—Erythema—Docetaxel—melanoma	0.000389	0.00132	CcSEcCtD
Betaxolol—Malnutrition—Docetaxel—melanoma	0.000389	0.00132	CcSEcCtD
Betaxolol—Hypersensitivity—Dactinomycin—melanoma	0.000389	0.00132	CcSEcCtD
Betaxolol—Atenolol—ABCB1—melanoma	0.000381	0.234	CrCbGaD
Betaxolol—Dysgeusia—Docetaxel—melanoma	0.000381	0.00129	CcSEcCtD
Betaxolol—Urticaria—Temozolomide—melanoma	0.000379	0.00129	CcSEcCtD
Betaxolol—Asthenia—Dactinomycin—melanoma	0.000378	0.00129	CcSEcCtD
Betaxolol—Body temperature increased—Temozolomide—melanoma	0.000377	0.00128	CcSEcCtD
Betaxolol—Muscle spasms—Docetaxel—melanoma	0.000374	0.00127	CcSEcCtD
Betaxolol—Hypersensitivity—Carmustine—melanoma	0.000364	0.00124	CcSEcCtD
Betaxolol—Diarrhoea—Dactinomycin—melanoma	0.000361	0.00123	CcSEcCtD
Betaxolol—Vomiting—Bleomycin—melanoma	0.000359	0.00122	CcSEcCtD
Betaxolol—Anaemia—Docetaxel—melanoma	0.000359	0.00122	CcSEcCtD
Betaxolol—Rash—Bleomycin—melanoma	0.000357	0.00121	CcSEcCtD
Betaxolol—Dermatitis—Bleomycin—melanoma	0.000356	0.00121	CcSEcCtD
Betaxolol—Asthenia—Carmustine—melanoma	0.000354	0.0012	CcSEcCtD
Betaxolol—Acebutolol—ABCB1—melanoma	0.000351	0.216	CrCbGaD
Betaxolol—Hypersensitivity—Temozolomide—melanoma	0.000351	0.00119	CcSEcCtD
Betaxolol—Syncope—Docetaxel—melanoma	0.000349	0.00118	CcSEcCtD
Betaxolol—Palpitations—Docetaxel—melanoma	0.000343	0.00117	CcSEcCtD
Betaxolol—Asthenia—Temozolomide—melanoma	0.000342	0.00116	CcSEcCtD
Betaxolol—Loss of consciousness—Docetaxel—melanoma	0.000342	0.00116	CcSEcCtD
Betaxolol—Cough—Docetaxel—melanoma	0.000339	0.00115	CcSEcCtD
Betaxolol—Diarrhoea—Carmustine—melanoma	0.000338	0.00115	CcSEcCtD
Betaxolol—Pruritus—Temozolomide—melanoma	0.000337	0.00115	CcSEcCtD
Betaxolol—Nausea—Bleomycin—melanoma	0.000336	0.00114	CcSEcCtD
Betaxolol—Vomiting—Dactinomycin—melanoma	0.000335	0.00114	CcSEcCtD
Betaxolol—Rash—Dactinomycin—melanoma	0.000332	0.00113	CcSEcCtD
Betaxolol—Myalgia—Docetaxel—melanoma	0.000331	0.00112	CcSEcCtD
Betaxolol—Chest pain—Docetaxel—melanoma	0.000331	0.00112	CcSEcCtD
Betaxolol—Arthralgia—Docetaxel—melanoma	0.000331	0.00112	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000329	0.00112	CcSEcCtD
Betaxolol—Dizziness—Carmustine—melanoma	0.000326	0.00111	CcSEcCtD
Betaxolol—Diarrhoea—Temozolomide—melanoma	0.000326	0.00111	CcSEcCtD
Betaxolol—Dry mouth—Docetaxel—melanoma	0.000324	0.0011	CcSEcCtD
Betaxolol—Confusional state—Docetaxel—melanoma	0.00032	0.00109	CcSEcCtD
Betaxolol—Oedema—Docetaxel—melanoma	0.000317	0.00108	CcSEcCtD
Betaxolol—Dizziness—Temozolomide—melanoma	0.000315	0.00107	CcSEcCtD
Betaxolol—Infection—Docetaxel—melanoma	0.000315	0.00107	CcSEcCtD
Betaxolol—Vomiting—Carmustine—melanoma	0.000314	0.00107	CcSEcCtD
Betaxolol—Nausea—Dactinomycin—melanoma	0.000313	0.00106	CcSEcCtD
Betaxolol—Shock—Docetaxel—melanoma	0.000312	0.00106	CcSEcCtD
Betaxolol—Rash—Carmustine—melanoma	0.000311	0.00106	CcSEcCtD
Betaxolol—Nervous system disorder—Docetaxel—melanoma	0.000311	0.00106	CcSEcCtD
Betaxolol—Dermatitis—Carmustine—melanoma	0.000311	0.00106	CcSEcCtD
Betaxolol—Thrombocytopenia—Docetaxel—melanoma	0.000311	0.00105	CcSEcCtD
Betaxolol—Tachycardia—Docetaxel—melanoma	0.00031	0.00105	CcSEcCtD
Betaxolol—Headache—Carmustine—melanoma	0.000309	0.00105	CcSEcCtD
Betaxolol—Skin disorder—Docetaxel—melanoma	0.000308	0.00105	CcSEcCtD
Betaxolol—Vomiting—Temozolomide—melanoma	0.000303	0.00103	CcSEcCtD
Betaxolol—Anorexia—Docetaxel—melanoma	0.000302	0.00103	CcSEcCtD
Betaxolol—Rash—Temozolomide—melanoma	0.000301	0.00102	CcSEcCtD
Betaxolol—Dermatitis—Temozolomide—melanoma	0.0003	0.00102	CcSEcCtD
Betaxolol—Headache—Temozolomide—melanoma	0.000299	0.00102	CcSEcCtD
Betaxolol—Metoprolol—ABCB1—melanoma	0.000297	0.182	CrCbGaD
Betaxolol—Hypotension—Docetaxel—melanoma	0.000296	0.00101	CcSEcCtD
Betaxolol—Nausea—Carmustine—melanoma	0.000293	0.000996	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000289	0.000982	CcSEcCtD
Betaxolol—Insomnia—Docetaxel—melanoma	0.000287	0.000975	CcSEcCtD
Betaxolol—Paraesthesia—Docetaxel—melanoma	0.000285	0.000968	CcSEcCtD
Betaxolol—Nausea—Temozolomide—melanoma	0.000283	0.000962	CcSEcCtD
Betaxolol—Dyspnoea—Docetaxel—melanoma	0.000283	0.000961	CcSEcCtD
Betaxolol—Dyspepsia—Docetaxel—melanoma	0.000279	0.000948	CcSEcCtD
Betaxolol—Decreased appetite—Docetaxel—melanoma	0.000276	0.000937	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Docetaxel—melanoma	0.000274	0.00093	CcSEcCtD
Betaxolol—Fatigue—Docetaxel—melanoma	0.000273	0.000929	CcSEcCtD
Betaxolol—Pain—Docetaxel—melanoma	0.000271	0.000921	CcSEcCtD
Betaxolol—Constipation—Docetaxel—melanoma	0.000271	0.000921	CcSEcCtD
Betaxolol—Feeling abnormal—Docetaxel—melanoma	0.000261	0.000888	CcSEcCtD
Betaxolol—Body temperature increased—Docetaxel—melanoma	0.000251	0.000852	CcSEcCtD
Betaxolol—Hypersensitivity—Docetaxel—melanoma	0.000234	0.000794	CcSEcCtD
Betaxolol—Asthenia—Docetaxel—melanoma	0.000228	0.000773	CcSEcCtD
Betaxolol—Pruritus—Docetaxel—melanoma	0.000224	0.000762	CcSEcCtD
Betaxolol—Diarrhoea—Docetaxel—melanoma	0.000217	0.000737	CcSEcCtD
Betaxolol—Dizziness—Docetaxel—melanoma	0.00021	0.000713	CcSEcCtD
Betaxolol—Vomiting—Docetaxel—melanoma	0.000202	0.000685	CcSEcCtD
Betaxolol—Rash—Docetaxel—melanoma	0.0002	0.000679	CcSEcCtD
Betaxolol—Dermatitis—Docetaxel—melanoma	0.0002	0.000679	CcSEcCtD
Betaxolol—Headache—Docetaxel—melanoma	0.000199	0.000675	CcSEcCtD
Betaxolol—Nausea—Docetaxel—melanoma	0.000188	0.00064	CcSEcCtD
Betaxolol—Propranolol—ABCB1—melanoma	0.00015	0.0921	CrCbGaD
Betaxolol—CYP2D6—Metabolism—HPSE—melanoma	2.66e-05	0.000484	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC6A11—melanoma	2.65e-05	0.000482	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIP4K2A—melanoma	2.65e-05	0.000482	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—RAC1—melanoma	2.63e-05	0.000478	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDNRB—melanoma	2.63e-05	0.000478	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CUBN—melanoma	2.61e-05	0.000475	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTK2B—melanoma	2.61e-05	0.000474	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTAP—melanoma	2.58e-05	0.000469	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTK2B—melanoma	2.55e-05	0.000464	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNA11—melanoma	2.54e-05	0.000461	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GAB2—melanoma	2.54e-05	0.000461	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FLT1—melanoma	2.53e-05	0.000459	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SDHD—melanoma	2.52e-05	0.000458	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—BSG—melanoma	2.52e-05	0.000458	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CSPG4—melanoma	2.52e-05	0.000458	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.52e-05	0.000458	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	2.5e-05	0.000455	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNA11—melanoma	2.48e-05	0.000451	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GAB2—melanoma	2.48e-05	0.000451	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FLT1—melanoma	2.47e-05	0.000449	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	2.45e-05	0.000445	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPAM—melanoma	2.44e-05	0.000444	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HDAC2—melanoma	2.39e-05	0.000434	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FOXO4—melanoma	2.39e-05	0.000434	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCR4—melanoma	2.39e-05	0.000434	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GNAQ—melanoma	2.36e-05	0.000429	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HDAC2—melanoma	2.34e-05	0.000424	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FOXO4—melanoma	2.34e-05	0.000424	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCR4—melanoma	2.34e-05	0.000424	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GNAQ—melanoma	2.31e-05	0.000419	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LUM—melanoma	2.3e-05	0.000418	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PHGDH—melanoma	2.3e-05	0.000418	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	2.27e-05	0.000413	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HPSE—melanoma	2.26e-05	0.00041	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.22e-05	0.000404	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SYK—melanoma	2.22e-05	0.000403	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CUBN—melanoma	2.21e-05	0.000402	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	2.2e-05	0.0004	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT3—melanoma	2.18e-05	0.000396	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ITGAV—melanoma	2.18e-05	0.000396	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NGFR—melanoma	2.18e-05	0.000396	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SYK—melanoma	2.17e-05	0.000394	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.15e-05	0.000391	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SDHD—melanoma	2.14e-05	0.000388	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—BSG—melanoma	2.14e-05	0.000388	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CSPG4—melanoma	2.14e-05	0.000388	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ITGAV—melanoma	2.13e-05	0.000387	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NGFR—melanoma	2.13e-05	0.000387	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT3—melanoma	2.13e-05	0.000387	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G6—melanoma	2.08e-05	0.000378	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPAM—melanoma	2.07e-05	0.000376	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SOCS1—melanoma	2.02e-05	0.000366	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	2.01e-05	0.000366	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—S100B—melanoma	2.01e-05	0.000365	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	2e-05	0.000363	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS1—melanoma	1.97e-05	0.000358	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	1.97e-05	0.000358	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—S100B—melanoma	1.97e-05	0.000358	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	1.96e-05	0.000355	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ERBB4—melanoma	1.92e-05	0.00035	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	1.92e-05	0.000349	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	1.91e-05	0.000346	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ERBB4—melanoma	1.88e-05	0.000342	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	1.88e-05	0.000341	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—VCAN—melanoma	1.87e-05	0.000339	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	1.87e-05	0.000339	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CD86—melanoma	1.84e-05	0.000335	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	1.84e-05	0.000335	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDN1—melanoma	1.83e-05	0.000332	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CD86—melanoma	1.8e-05	0.000328	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	1.8e-05	0.000328	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDN1—melanoma	1.79e-05	0.000325	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CSF2—melanoma	1.79e-05	0.000325	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF1—melanoma	1.79e-05	0.000325	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—IL2—melanoma	1.76e-05	0.00032	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G6—melanoma	1.76e-05	0.00032	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—E2F1—melanoma	1.75e-05	0.000318	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF1—melanoma	1.75e-05	0.000318	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CSF2—melanoma	1.75e-05	0.000318	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	1.74e-05	0.000317	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	1.73e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—IL2—melanoma	1.72e-05	0.000313	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ITGB3—melanoma	1.72e-05	0.000312	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCA—melanoma	1.72e-05	0.000312	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—E2F1—melanoma	1.71e-05	0.000311	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	1.7e-05	0.00031	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	1.69e-05	0.000308	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SPP1—melanoma	1.68e-05	0.000306	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ITGB3—melanoma	1.68e-05	0.000305	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCA—melanoma	1.68e-05	0.000305	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	1.68e-05	0.000305	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	1.67e-05	0.000304	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SPP1—melanoma	1.65e-05	0.000299	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	1.64e-05	0.000298	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	1.64e-05	0.000298	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL2—melanoma	1.6e-05	0.000291	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TERT—melanoma	1.59e-05	0.00029	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RAC1—melanoma	1.59e-05	0.000289	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—VCAN—melanoma	1.58e-05	0.000287	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP17A1—melanoma	1.58e-05	0.000286	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL2—melanoma	1.57e-05	0.000284	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TERT—melanoma	1.56e-05	0.000283	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RAC1—melanoma	1.56e-05	0.000283	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.52e-05	0.000277	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.5e-05	0.000272	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.49e-05	0.000271	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNA11—melanoma	1.49e-05	0.00027	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KDR—melanoma	1.46e-05	0.000265	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FASN—melanoma	1.46e-05	0.000264	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.44e-05	0.000262	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC5A5—melanoma	1.43e-05	0.00026	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KDR—melanoma	1.43e-05	0.000259	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FN1—melanoma	1.4e-05	0.000255	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GNAQ—melanoma	1.38e-05	0.000251	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD44—melanoma	1.38e-05	0.000251	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.37e-05	0.00025	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FN1—melanoma	1.37e-05	0.000249	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CD80—melanoma	1.35e-05	0.000244	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APC—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KIT—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP17A1—melanoma	1.33e-05	0.000242	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EGF—melanoma	1.33e-05	0.000241	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP1B1—melanoma	1.33e-05	0.000241	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CD80—melanoma	1.32e-05	0.000239	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.32e-05	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KIT—melanoma	1.31e-05	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APC—melanoma	1.31e-05	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.31e-05	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.31e-05	0.000239	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.3e-05	0.000236	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EGF—melanoma	1.3e-05	0.000236	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.29e-05	0.000234	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.26e-05	0.000229	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNA11—melanoma	1.26e-05	0.000229	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.26e-05	0.000229	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.24e-05	0.000224	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FASN—melanoma	1.23e-05	0.000224	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.23e-05	0.000223	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.22e-05	0.000222	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.22e-05	0.000222	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC5A5—melanoma	1.21e-05	0.00022	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.2e-05	0.000219	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.2e-05	0.000218	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.2e-05	0.000217	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.19e-05	0.000216	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.18e-05	0.000215	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GNAQ—melanoma	1.17e-05	0.000213	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD44—melanoma	1.17e-05	0.000213	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.17e-05	0.000212	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.16e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.16e-05	0.00021	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.16e-05	0.00021	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.15e-05	0.000208	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.14e-05	0.000208	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.14e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.13e-05	0.000205	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.13e-05	0.000205	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP1B1—melanoma	1.12e-05	0.000204	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.11e-05	0.000201	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCB1—melanoma	1.09e-05	0.000198	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.06e-05	0.000193	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.06e-05	0.000192	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.04e-05	0.000189	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.04e-05	0.000189	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MDM2—melanoma	1.03e-05	0.000188	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.03e-05	0.000187	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.02e-05	0.000185	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.01e-05	0.000183	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PRKCA—melanoma	1e-05	0.000183	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ERCC2—melanoma	9.97e-06	0.000181	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.91e-06	0.00018	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL8—melanoma	9.89e-06	0.00018	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HRAS—melanoma	9.83e-06	0.000179	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL8—melanoma	9.68e-06	0.000176	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	9.66e-06	0.000175	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HRAS—melanoma	9.61e-06	0.000175	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	9.56e-06	0.000174	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—melanoma	9.47e-06	0.000172	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL2—melanoma	9.45e-06	0.000172	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	9.45e-06	0.000172	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—melanoma	9.41e-06	0.000171	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	9.35e-06	0.00017	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—melanoma	9.26e-06	0.000168	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCB1—melanoma	9.25e-06	0.000168	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL2—melanoma	9.25e-06	0.000168	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCND1—melanoma	9.22e-06	0.000167	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—melanoma	9.2e-06	0.000167	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	9.13e-06	0.000166	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCND1—melanoma	9.01e-06	0.000164	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—melanoma	8.95e-06	0.000163	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	8.93e-06	0.000162	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	8.92e-06	0.000162	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTEN—melanoma	8.89e-06	0.000162	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NFKB1—melanoma	8.85e-06	0.000161	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—melanoma	8.75e-06	0.000159	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	8.72e-06	0.000158	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTEN—melanoma	8.7e-06	0.000158	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—melanoma	8.68e-06	0.000158	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NFKB1—melanoma	8.66e-06	0.000157	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PRKCA—melanoma	8.51e-06	0.000155	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—melanoma	8.49e-06	0.000154	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ERCC2—melanoma	8.44e-06	0.000153	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—melanoma	8.03e-06	0.000146	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STAT3—melanoma	7.96e-06	0.000144	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NRAS—melanoma	7.94e-06	0.000144	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CG—melanoma	7.87e-06	0.000143	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—melanoma	7.86e-06	0.000143	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STAT3—melanoma	7.78e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NRAS—melanoma	7.76e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK3—melanoma	7.6e-06	0.000138	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—melanoma	7.6e-06	0.000138	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK3—melanoma	7.43e-06	0.000135	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MYC—melanoma	7.39e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK1—melanoma	7.23e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MYC—melanoma	7.23e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EGFR—melanoma	7.23e-06	0.000131	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK1—melanoma	7.07e-06	0.000128	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EGFR—melanoma	7.07e-06	0.000128	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.99e-06	0.000127	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CD—melanoma	6.92e-06	0.000126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KRAS—melanoma	6.83e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—melanoma	6.83e-06	0.000124	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KRAS—melanoma	6.68e-06	0.000121	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CG—melanoma	6.67e-06	0.000121	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—melanoma	6.44e-06	0.000117	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	6.28e-06	0.000114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	6.14e-06	0.000111	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TP53—melanoma	6.07e-06	0.00011	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CB—melanoma	6.03e-06	0.00011	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—melanoma	5.98e-06	0.000109	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TP53—melanoma	5.94e-06	0.000108	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CD—melanoma	5.86e-06	0.000106	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HRAS—melanoma	5.81e-06	0.000105	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—melanoma	5.79e-06	0.000105	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HRAS—melanoma	5.68e-06	0.000103	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—melanoma	5.56e-06	0.000101	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—melanoma	5.44e-06	9.87e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTEN—melanoma	5.21e-06	9.47e-05	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—melanoma	5.13e-06	9.31e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CB—melanoma	5.11e-06	9.28e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—melanoma	5.06e-06	9.19e-05	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—melanoma	5.01e-06	9.11e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTEN—melanoma	4.41e-06	8.02e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CA—melanoma	3.68e-06	6.68e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CA—melanoma	3.11e-06	5.66e-05	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—melanoma	3e-06	5.46e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—melanoma	2.54e-06	4.62e-05	CbGpPWpGaD
